PLUS1
0.4304
-0.0399 (-8.48%)
-0.0399 (-8.48%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 67,084 |
|
|||||
| News | - | ||||||
| Day High | 0.486 | Low High |
|||||
| Day Low | 0.4261 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nymox Pharmaceutical Corp | NYMX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0399 | -8.48% | 0.4304 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.476 | 0.4261 | 0.486 | 0.4304 | 0.470301 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 160 | 67,084 | $ 0.4415035 | $ 29,618 | - | 0.185 - 2.10 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:07:09 | formt | 1,595 | $ 0.4261 | USD |
Period:
Draw Mode:
Nymox Pharmaceutical Corp Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 38.96M | 90.52M | 42.96M | $ - | $ - | -0.15 | -4.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 31.20% |
Nymox Pharmaceutical News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NYMX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.44 | 0.499 | 0.42 | 0.4446212 | 66,263 | -0.0096 | -2.18% |
| 1 Month | 0.4046 | 0.50 | 0.3901 | 0.4418464 | 54,168 | 0.0258 | 6.38% |
| 3 Months | 0.315 | 0.7427 | 0.2722 | 0.4476441 | 209,678 | 0.1154 | 36.63% |
| 6 Months | 0.38 | 0.7427 | 0.2722 | 0.4445163 | 148,030 | 0.0504 | 13.26% |
| 1 Year | 1.68 | 2.10 | 0.185 | 0.6386373 | 242,772 | -1.25 | -74.38% |
| 3 Years | 3.16 | 4.90 | 0.185 | 1.70 | 227,711 | -2.73 | -86.38% |
| 5 Years | 3.36 | 4.90 | 0.185 | 1.91 | 183,830 | -2.93 | -87.19% |
Nymox Pharmaceutical Description
| Nymox Pharmaceutical Corp is a biopharmaceutical company focused on developing its drug candidate, NX-1207, for the treatment of BPH and the treatment of low-grade localized prostate cancer. It markets NicAlert and TobacAlert tests that use urine or saliva to detect use of tobacco products. It operates in a single segment, which is research and development of products for the aging population. The company's geographical segments include Canada, United States, and Europe. |